HCC94 Cells

The HCC94 cell line is a model used for studying cervical cancer, a condition commonly linked to human papillomavirus (HPV) infection. This cell line has been instrumental in understanding mechanisms underlying chemotherapy resistance, particularly through metabolic pathways. Recent studies have shown that in cervical cancer stem cells (CSCs) derived from HCC94, enzymes involved in glycogen metabolism, such as PCK1 and phosphorylated glycogen phosphorylase (pPYGL), facilitate the breakdown of glycogen. This process directs glucose into the pentose phosphate pathway (PPP), producing NADPH and aiding in reactive oxygen species (ROS) clearance. This mechanism contributes to the cell’s survival under chemotherapy, thereby fostering resistance.

Further research has demonstrated that knocking down PCK1 in HCC94 CSCs can reduce NADPH production and impair the cells’ ability to clear ROS, enhancing their sensitivity to chemotherapy. These findings underline the potential of targeting metabolic pathways like PPP and glycogen breakdown as strategies for overcoming drug resistance in cervical cancer. This understanding may pave the way for new therapeutic approaches aimed at disrupting ROS management mechanisms to improve treatment outcomes in cervical cancer.